Borealis Biosciences
Vancouver
About Borealis Biosciences
Borealis Biosciences is a company in the field of next-generation RNA medicines, specializing in molecular and cellular biology, vivarium space, chemistry, and analytical capabilities.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $180.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Dec 2024)
- Website: borealisbio.com
Industries & Categories
Biotechnology, Life Science, Medical
Social Profiles
Canonical: https://fsome.com/organization/borealis-biosciences-36931 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.